The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future

Descripción del Articulo

Objective: Therapeutic management of ductal carcinoma in situ (DCIS) is heterogeneous among countries worldwide, and some treatment indications are still controversial. To investigate DCIS management in different countries
Detalles Bibliográficos
Autores: Mathelin, C, Lodi, M, Alghamdi, K, Arboleda-Osorio, B, Avisar, E, Anyanwu, S, Boubnider, M, Costa, MM, Elder, E, Elonge, T, Gebrim, L, Hao, X, Imoto, S, Meka, E, Mouelle, M, Mundinger, A, Ostapenko, V, Özbaş, S, Özmen, T, Özmen, V, Pienkowski, T, Sarria-Bardales, G, Selim, A, Semiglazov, V, Schneebaum, S
Formato: artículo
Fecha de Publicación:2022
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:20.500.14703/303
Enlace del recurso:https://hdl.handle.net/20.500.14703/303
Nivel de acceso:acceso abierto
Materia:clinical practices, survey
Ductal carcinoma in situ
innovative approaches
precision medicine
treatment de-escalation
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_b100b76989fd8259b3f99cbd2813d0c1
oai_identifier_str oai:repositorio.inen.sld.pe:20.500.14703/303
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
dc.title.none.fl_str_mv The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
title The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
spellingShingle The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
Mathelin, C
clinical practices, survey
Ductal carcinoma in situ
innovative approaches
precision medicine
treatment de-escalation
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
title_full The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
title_fullStr The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
title_full_unstemmed The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
title_sort The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
author Mathelin, C
author_facet Mathelin, C
Lodi, M
Alghamdi, K
Arboleda-Osorio, B
Avisar, E
Anyanwu, S
Boubnider, M
Costa, MM
Elder, E
Elonge, T
Gebrim, L
Hao, X
Imoto, S
Meka, E
Mouelle, M
Mundinger, A
Ostapenko, V
Özbaş, S
Özmen, T
Özmen, V
Pienkowski, T
Sarria-Bardales, G
Selim, A
Semiglazov, V
Schneebaum, S
author_role author
author2 Lodi, M
Alghamdi, K
Arboleda-Osorio, B
Avisar, E
Anyanwu, S
Boubnider, M
Costa, MM
Elder, E
Elonge, T
Gebrim, L
Hao, X
Imoto, S
Meka, E
Mouelle, M
Mundinger, A
Ostapenko, V
Özbaş, S
Özmen, T
Özmen, V
Pienkowski, T
Sarria-Bardales, G
Selim, A
Semiglazov, V
Schneebaum, S
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Mathelin, C
Lodi, M
Alghamdi, K
Arboleda-Osorio, B
Avisar, E
Anyanwu, S
Boubnider, M
Costa, MM
Elder, E
Elonge, T
Gebrim, L
Hao, X
Imoto, S
Meka, E
Mouelle, M
Mundinger, A
Ostapenko, V
Özbaş, S
Özmen, T
Özmen, V
Pienkowski, T
Sarria-Bardales, G
Selim, A
Semiglazov, V
Schneebaum, S
dc.subject.none.fl_str_mv clinical practices, survey
Ductal carcinoma in situ
innovative approaches
precision medicine
treatment de-escalation
topic clinical practices, survey
Ductal carcinoma in situ
innovative approaches
precision medicine
treatment de-escalation
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Objective: Therapeutic management of ductal carcinoma in situ (DCIS) is heterogeneous among countries worldwide, and some treatment indications are still controversial. To investigate DCIS management in different countries
publishDate 2022
dc.date.accessioned.none.fl_str_mv 2025-01-02T14:42:21Z
dc.date.available.none.fl_str_mv 2025-01-02T14:42:21Z
dc.date.issued.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.4274/ejbh.galenos.2022.2022-4-3
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.14703/303
dc.identifier.journal.none.fl_str_mv European Journal of Breast Health
identifier_str_mv 10.4274/ejbh.galenos.2022.2022-4-3
European Journal of Breast Health
url https://hdl.handle.net/20.500.14703/303
dc.language.iso.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Galenos Publishing House
dc.publisher.country.none.fl_str_mv TU
publisher.none.fl_str_mv Galenos Publishing House
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
bitstream.url.fl_str_mv https://repositorio.inen.sld.pe/backend/api/core/bitstreams/87d7b0a6-33ca-4510-86b4-74c98bf5817d/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/fc6b2795-874b-4f8d-a208-eae77640ceb3/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/66b430b3-755f-4878-912e-a3ef2b4ef9e8/download
bitstream.checksum.fl_str_mv 239baea7b62b88d34250a84835bfc91c
e3f15fb376b07a06b94b7d1ac5a686c4
e7bf03f977a72f07f1b232ee14239c36
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio del Instituto Nacional de Enfermedades Neoplásicas
repository.mail.fl_str_mv repositorio@inen.sld.pe
_version_ 1868438555884257280
spelling PublicationMathelin, CLodi, MAlghamdi, KArboleda-Osorio, BAvisar, EAnyanwu, SBoubnider, MCosta, MMElder, EElonge, TGebrim, LHao, XImoto, SMeka, EMouelle, MMundinger, AOstapenko, VÖzbaş, SÖzmen, TÖzmen, VPienkowski, TSarria-Bardales, GSelim, ASemiglazov, VSchneebaum, S2025-01-02T14:42:21Z2025-01-02T14:42:21Z202210.4274/ejbh.galenos.2022.2022-4-3https://hdl.handle.net/20.500.14703/303European Journal of Breast HealthObjective: Therapeutic management of ductal carcinoma in situ (DCIS) is heterogeneous among countries worldwide, and some treatment indications are still controversial. To investigate DCIS management in different countriesidentify both consensual practices and controversial topicsand survey opinions about the future management of DCIS. Materials and Methods: The Senologic International Society network members participated to an online survey using a questionnaire, between November 2021 and February 2022. Results: Twenty-two responses from 20 different countries showed that organized breast cancer screening programs were present for 87% participants, and DCIS cases represented 13.7% of all breast cancers. Most participants used the grade classification (100%), the morphological classification (78%) and performed immunohistochemistry assays (73%). In case of conservative treatment, the mean re-excision rate was 10.3% and clear margins of mean 2.5 mm were considered healthy. Radical mastectomy rate was 35.5% with a breast reconstruction rate of 53%. Tumor bed boost indications were heterogeneous, and 73% of participants indicated hormone therapy for hormone-positive DCIS. Surgery and radiotherapy omission for some low-risk DCIS were considered by 73% of participants. Multigene assays were used by 43% of participants. Concerning future changes in DCIS management, participants mostly answered surgical de-escalation (48%), radiotherapy de-escalation (35) and/or active surveillance for some cases (22%). Conclusion: This survey provided an overview of the current practices of DCIS management worldwide. It showed that some areas are rather consensual: incidence increases over time, treatment in young women, pathological classifications, definition of healthy margins, the skin-sparing mastectomy and immediate breast reconstruction. However, some topics are still debated and result in heterogeneous practices, such as evolution in the age of diagnosis, the benefit of de-escalation in low-risk DCIS among elderly women, indications for hormone therapy, radiotherapy omission, or multigene assays. Further evidence is needed to reach consensus on these points, and innovative approaches are still under evaluation in clinical trials. The International Senologic Society, by its members, encourages precision medicine and personalized treatments for DCIS, to avoid overtreatment and overdiagnosis, and provide better healthcare to women with DCIS. application/pdfengGalenos Publishing HouseTUinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/clinical practices, surveyDuctal carcinoma in situinnovative approachesprecision medicinetreatment de-escalationhttps://purl.org/pe-repo/ocde/ford#3.02.21The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Futureinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINALejbh-18-205.pdfapplication/pdf641141https://repositorio.inen.sld.pe/backend/api/core/bitstreams/87d7b0a6-33ca-4510-86b4-74c98bf5817d/download239baea7b62b88d34250a84835bfc91cMD51trueAnonymousREADTEXTejbh-18-205.pdf.txtWritten by FormatFilter org.dspace.app.mediafilter.TikaTextExtractionFilter on 2025-08-22T08:03:18Z (GMT).Extracted texttext/plain55470https://repositorio.inen.sld.pe/backend/api/core/bitstreams/fc6b2795-874b-4f8d-a208-eae77640ceb3/downloade3f15fb376b07a06b94b7d1ac5a686c4MD52falseAnonymousREADTHUMBNAILejbh-18-205.pdf.jpgWritten by FormatFilter org.dspace.app.mediafilter.PDFBoxThumbnail on 2025-08-22T08:03:19Z (GMT).Generated Thumbnailimage/jpeg38357https://repositorio.inen.sld.pe/backend/api/core/bitstreams/66b430b3-755f-4878-912e-a3ef2b4ef9e8/downloade7bf03f977a72f07f1b232ee14239c36MD53falseAnonymousREAD20.500.14703/303oai:repositorio.inen.sld.pe:20.500.14703/3032026-02-15T18:29:06.836Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessopen.accesshttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe
score 12.824051
The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares